MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner

Biochemical and Biophysical Research Communications

Volumn 383, Issue 3, 2009, Pages 373-377

  Miyamoto, Kana ^a   Ninomiya, Ken ^a   Sonoda, Koh Hei ^b   Miyauchi, Yoshiteru ^a   Hoshi, Hiroko ^a   Iwasaki, Ryotaro ^a   Miyamoto, Hiroya ^a   Yoshida, Shigeyuki ^a   Sato, Yuiko ^a   Morioka, Hideo ^a   Chiba, Kazuhiro ^a   Egashira, Kensuke ^b   Suda, Toshio ^a   Toyama, Yoshiaki ^a   Miyamoto, Takeshi ^a,c  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autocrine paracrine; DC STAMP; MCP 1; Osteoclast

Indexed keywords

CATHEPSIN K; MEMBRANE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL FUSION; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELL FUSION; CHEMOKINE CCL2; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; OSTEOCLASTS; RANK LIGAND;

MUS;

EID: 67349232758     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.020     Document Type: Article

References (34)

1. Miyamoto T., and Suda T. Differentiation and function of osteoclasts. Keio J. Med. 52 (2003) 1-7
2. Schett G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res. Ther. 9 (2007) 203
3. Roodman G.D. Treatment strategies for bone disease. Bone Marrow Transplant. 40 (2007) 1139-1146
4. Cicek M., and Oursler M.J. Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev. 25 (2006) 635-644
5. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L.D., and Nishikawa S. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (1990) 442-444
6. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95 (1998) 3597-3602
7. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., Miyata T., Anderson D.M., and Suda T. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J. Exp. Med. 190 (1999) 1741-1754
8. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., and Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
9. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., Daro E., Smith J., Tometsko M.E., Maliszewski C.R., Armstrong A., Shen V., Bain S., Cosman D., Anderson D., Morrissey P.J., Peschon J.J., and Schuh J. RANK is essential for osteoclast and lymph node development. Genes Dev. 13 (1999) 2412-2424
10. Thomas R.J., Guise T.A., Yin J.J., Elliott J., Horwood N.J., Martin T.J., and Gillespie M.T. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140 (1999) 4451-4458
11. Nagai M., and Sato N. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem. Biophys. Res. Commun. 257 (1999) 719-723
12. Tangirala R.K., Murao K., and Quehenberger O. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J. Biol. Chem. 272 (1997) 8050-8056
13. Kitamoto S., and Egashira K. Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease. J. Atheroscler. Thromb. 9 (2002) 261-265
14. Kim M.S., Day C.J., and Morrison N.A. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J. Biol. Chem. 280 (2005) 16163-16169
15. Kim M.S., Day C.J., Selinger C.I., Magno C.L., Stephens S.R., and Morrison N.A. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J. Biol. Chem. 281 (2006) 1274-1285
16. Li X., Qin L., Bergenstock M., Bevelock L.M., Novack D.V., and Partridge N.C. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J. Biol. Chem. 282 (2007) 33098-33106
17. Hounoki H., Sugiyama E., Mohamed S.G., Shinoda K., Taki H., Abdel-Aziz H.O., Maruyama M., Kobayashi M., and Miyahara T. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Bone 42 (2008) 765-774
18. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., Morita K., Ninomiya K., Suzuki T., Miyamoto K., Oike Y., Takeya M., Toyama Y., and Suda T. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202 (2005) 345-351
19. Yagi M., Ninomiya K., Fujita N., Suzuki T., Iwasaki R., Morita K., Hosogane N., Matsuo K., Toyama Y., Suda T., and Miyamoto T. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J. Bone Miner. Res. 22 (2007) 992-1001
20. Miyamoto T. The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity. Mod. Rheumatol. 16 (2006) 341-342
21. Kukita T., Wada N., Kukita A., Kakimoto T., Sandra F., Toh K., Nagata K., Iijima T., Horiuchi M., Matsusaki H., Hieshima K., Yoshie O., and Nomiyama H. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J. Exp. Med. 200 (2004) 941-946
22. Kim K., Lee S.H., Ha Kim J., Choi Y., and Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22 (2008) 176-185
23. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., and Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187 (1998) 601-608
24. Miyamoto T., Arai F., Ohneda O., Takagi K., Anderson D.M., and Suda T. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 96 (2000) 4335-4343
25. Miyamoto T., Ohneda O., Arai F., Iwamoto K., Okada S., Takagi K., Anderson D.M., and Suda T. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98 (2001) 2544-2554
26. Matsumoto M., Kogawa M., Wada S., Takayanagi H., Tsujimoto M., Katayama S., Hisatake K., and Nogi Y. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 279 (2004) 45969-45979
27. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20 (1999) 345-357
28. Yoshino M., Yamazaki H., Yoshida H., Niida S., Nishikawa S., Ryoke K., Kunisada T., and Hayashi S. Reduction of osteoclasts in a critical embryonic period is essential for inhibition of mouse tooth eruption. J. Bone Miner. Res. 18 (2003) 108-116
29. Koch A.E., Kunkel S.L., Harlow L.A., Johnson B., Evanoff H.L., Haines G.K., Burdick M.D., Pope R.M., and Strieter R.M. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90 (1992) 772-779
30. Wise G.E., Frazier-Bowers S., and D'Souza R.N. Cellular, molecular, and genetic determinants of tooth eruption. Crit. Rev. Oral Biol. Med. 13 (2002) 323-334
31. Lu Y., Cai Z., Xiao G., Keller E.T., Mizokami A., Yao Z., Roodman G.D., and Zhang J. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res. 67 (2007) 3646-3653
32. Aggarwal R., Ghobrial I.M., and Roodman G.D. Chemokines in multiple myeloma. Exp. Hematol. 34 (2006) 1289-1295
33. Cappellen D., Luong-Nguyen N.H., Bongiovanni S., Grenet O., Wanke C., and Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J. Biol. Chem. 277 (2002) 21971-21982
34. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., Kumegawa M., Kimura T., and Takeya T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277 (2002) 41147-41156